Stockreport

Takeda ProThera Collaboration, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF SummaryTakeda teams up with ProThera to develop therapies for acute inflammatory conditions.Gilead slumps on leaked document showing remdesivir failure.Daxor jumps on Do [Read more]